Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 17Thymosin Alpha-1 literatureeuropepmc · Observational2026

Proximal tubule reabsorptive dysfunction and risk of cardiovascular death among community-living adults: the HUNT-3 cohort.

Higher levels of urinary A1M and B2M are associated with an increased risk of cardiovascular death, but the clinical implications of these findings require further investigation.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the thymosin alpha-1 corpus
2
Preclinical
12
Observational · this one
0
Open-label
2
Randomised
1
Reviews

Summary and findings

This study evaluated the association between proximal tubule dysfunction and cardiovascular death in a general population. It involved 1246 participants, measuring urinary alpha-1 microglobulin (A1M) and beta-2 microglobulin (B2M). Over a median follow-up of 13 years, 166 cardiovascular deaths were recorded.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
1-SD higher urine A1M associated with HR 1.33 (95% CI 1.12-1.58) for cardiovascular death.2026

Abstract

The authors’ words, as europepmc supplied them

<h4>Aims</h4>Proximal tubule dysfunction in the kidney is associated with cardiovascular disease (CVD) in populations with prevalent chronic kidney disease (CKD). We sought to evaluate the nature of this association in the general population.<h4>Methods and results</h4>We conducted a case-cohort study within the North Trøndelag Health Study (HUNT-3). We randomly sampled 1246 participants and all cases of cardiovascular death. Alpha-1 microglobulin (A1M) and beta-2 microglobulin (B2M) were measured in urine to assess proximal tubule reabsorptive dysfunction. Cardiovascular death was assessed using the Norwegian Cause of Death registry. We estimated the association of each biomarker with cardiovascular death after adjustment for baseline characteristics, including estimated glomerular filtration rate (eGFR) and albuminuria. Mean participant age was 51 years, 55% were female. Median urine albumin-to-creatinine ratio was 1.3 [interquartile range (IQR) 1.0-1.8] mg/mmol and mean eGFR was 98 (SD 17) mL/min/1.73 m<sup>2</sup>. Cardiovascular death occurred in 166 participants over a median follow-up of 13 years. The weighted incidence among those with low-normal, mid-normal, high-normal, and elevated A1M was 0.8 (0.6-1.1), 1.5 (1.0-2.0), 2.0 (1.3-2.6), and 4.5 (2.6-6.4) per cent, respectively. After adjustment for baseline characteristics, 1-SD higher urine A1M [hazard ratio (HR) 1.33, 95% confidence interval (CI) 1.12-1.58] and urine B2M (HR 1.28, 95% CI 1.10-1.48) were each associated with higher risk of cardiovascular death. We did not observe interaction across subgroups based on age, sex, albuminuria, or prevalent CVD.<h4>Conclusion</h4>In a population-based cohort of adults, proximal tubule reabsorptive dysfunction, as indicated by elevated levels of urinary A1M and B2M, was associated with higher risk of cardiovascular death independent of eGFR and albuminuria.

Elsewhere in the Thymosin Alpha-1 corpus

BThymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency in vitro.Virulence · 2026 · Intracellular p24 levels in CD4+ T cells decreased significantly, p=0.002.HumanDReply to 'F508del-CFTR is not corrected by thymosin α1'.Nature medicine · 2018BF508del-CFTR is not corrected by thymosin α1.Nature medicine · 2018In vitroAThe efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.BMJ (Clinical research ed.) · 2025 · 28-day all-cause mortality: 23.4% (127/542) in thymosin α1 group vs 24.1% (132/547) in placebo group, hazard ratio 0.99, 95% CI 0.77 to 1.27, P=0.93.HumanBPrecision biomarker discovery in hypertension through explainable AI and proteomics.europepmc · 2026 · AUROC = 0.7985 for CatBoost classifier.HumanBExploration and optimization of a respiratory outpatient triage model during the X disease epidemic: A retrospective observational study.europepmc · 2026 · Mean daily patient throughput of 550.43 (SD ± 284.13) individuals.Human